Jan 14 2025 05:25
HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced the...
Jan 14 2025 04:58
CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers
Jan 14 2025 04:05
Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55%
Jan 14 2025 11:47
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market by Type, Technology, Indication, ROA, End User - Global Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.The...
Jan 14 2025 10:55
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases, By Service, By Sponsor, By Region, And Segment Forecasts,...
Jan 14 2025 10:53
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by...
Jan 14 2025 09:00
FRAMINGHAM, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consulting and research organization, announces the global launch of its innovative technology platform SpherePX, designed to drive...
Jan 14 2025 08:30
DIFS Technology: A Potential Game-Changer for Mental Health Treatments
Jan 14 2025 08:02
-- Interim data from Cohort 4 expected Q1 2025 --MIAMI, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004,...
Jan 14 2025 08:00
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence Assessments of ALLEVYN LIFE Sacrum...